|
PTBP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.135830E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.424300E-02 |
| Normal-vs-Stage2 |
5.445700E-02 |
| Normal-vs-Stage3 |
2.008400E-02 |
| Normal-vs-Stage4 |
1.118470E-02 |
| Stage1-vs-Stage2 |
4.510800E-01 |
| Stage1-vs-Stage3 |
3.185000E-01 |
| Stage1-vs-Stage4 |
2.543400E-01 |
| Stage2-vs-Stage3 |
9.817400E-01 |
| Stage2-vs-Stage4 |
7.978000E-01 |
| Stage3-vs-Stage4 |
7.373800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.246030E-02 |
| Normal-vs-AfricanAmerican |
6.768000E-01 |
| Normal-vs-Asian |
9.555000E-01 |
| Caucasian-vs-AfricanAmerican |
1.822610E-01 |
| Caucasian-vs-Asian |
1.879600E-02 |
| AfricanAmerican-vs-Asian |
7.043600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.168100E-02 |
| Normal-vs-Female |
1.245540E-02 |
| Male-vs-Female |
8.880200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.741230E-01 |
| Normal-vs-Age(41-60Yrs) |
8.183500E-03 |
| Normal-vs-Age(61-80Yrs) |
3.624200E-03 |
| Normal-vs-Age(81-100Yrs) |
8.172800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.523030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.402100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.781400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.525600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.911200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.339600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.649820E-02 |
| Classical-VS-Follicular |
1.512440E-02 |
| Classical-VS-Other |
7.985400E-01 |
| Classical-VS-Normal |
1.942030E-01 |
| Tall-VS-Follicular |
5.747800E-01 |
| Tall-VS-Other |
1.286230E-01 |
| Tall-VS-Normal |
1.542850E-03 |
| Follicular-VS-Other |
3.214000E-01 |
| Follicular-VS-Normal |
2.724200E-03 |
| Other-VS-Normal |
7.653800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.405940E-02 |
| Normal-vs-N1 |
7.910500E-02 |
| N0-vs-N1 |
8.687800E-01 |
|
|
